Results 321 to 330 of about 312,657 (354)

Effect of follicle-stimulating hormone dose on the risk of being classified as suboptimal responders according to the POSEIDON criteria. [PDF]

J Assist Reprod Genet
Hochberg A, Dahan MH, Yarali H, Vuong LN, Esteves SC.   +4 more
europepmc   +1 more source

Induction of final follicle maturation with a gonadotropin-releasing hormone agonist in women at risk of ovarian hyperstimulation syndrome undergoing gonadotropin stimulation and intrauterine insemination: Proof-of-concept study

, 2012
Johnny Awwad, Antoine Hannoun, A Khalil, Younes Z.M.H., Ghina Ghazeeri   +4 more
openalex   +1 more source

Hyperreactio luteinalis and follicle-stimulating hormone receptor gene activation mutations: A case report. [PDF]

Int J Surg Case Rep
Yang WX, Qin Y, Wang TT, Zhao S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women

International Journal of Fertility and Sterility, 2015
Background The objective of our study was to identify the correlations between the tests currently used in ovarian reserve assessment: anti-Mullerian hormone (AMH), follicle stimulating hormone (FSH) and antral follicle count (AFC) and to distinguish the
L. Barbakadze, Jenara Kristesashvili, N. Khonelidze, G. Tsagareĭshvili   +3 more
semanticscholar   +1 more source

Follicle-stimulating hormone

Handbook of Hormones, 2021
H. Ando
semanticscholar   +1 more source

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung, Kimberly D Miller, Rebecca L Siegel   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly